Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Genelux Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GNLX
Nasdaq
2836
www.genelux.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Genelux Corporation
June 2025's Promising Penny Stocks For Savvy Investors
- Jun 16th, 2025 12:04 pm
Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should Know
- Jun 2nd, 2025 10:00 am
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates
- May 6th, 2025 2:10 pm
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
- May 1st, 2025 2:05 pm
Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year?
- Apr 18th, 2025 7:40 am
Genelux Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
- Mar 30th, 2025 7:48 am
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- Mar 28th, 2025 2:10 pm
Down -29.7% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
- Mar 28th, 2025 7:35 am
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
- Mar 25th, 2025 6:31 am
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
- Mar 25th, 2025 6:30 am
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
- Mar 25th, 2025 6:30 am
Why Genelux Corporation (GNLX) is Skyrocketing So Far in 2025
- Mar 2nd, 2025 7:39 am
Genelux Corporation Announces New Chief Financial Officer
- Feb 3rd, 2025 4:45 am
We Think Genelux (NASDAQ:GNLX) Needs To Drive Business Growth Carefully
- Jan 24th, 2025 6:51 am
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
- Dec 13th, 2024 5:01 am
These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts
- Nov 15th, 2024 7:50 am
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
- Nov 14th, 2024 2:05 pm
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
- Nov 6th, 2024 2:01 pm
Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well
- Oct 31st, 2024 5:37 am
Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp
- Oct 25th, 2024 11:01 am
Scroll